BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26698861)

  • 1. Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer.
    Riser BL; Barnes JL; Varani J
    J Cell Commun Signal; 2015 Dec; 9(4):327-39. PubMed ID: 26698861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
    Riser BL; Najmabadi F; Perbal B; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC; Peterson DR
    J Cell Commun Signal; 2010 Mar; 4(1):39-50. PubMed ID: 20195391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
    Kubota S; Kawata K; Hattori T; Nishida T
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy.
    Riser BL; Najmabadi F; Garchow K; Barnes JL; Peterson DR; Sukowski EJ
    Am J Pathol; 2014 Nov; 184(11):2908-21. PubMed ID: 25193594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.
    Jun JI; Lau LF
    Nat Rev Drug Discov; 2011 Dec; 10(12):945-63. PubMed ID: 22129992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2.
    Leask A
    J Cell Commun Signal; 2010 Oct; 4(3):155-6. PubMed ID: 21063505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying the CCN Proteins in Fibrosis.
    Hutchenreuther J; Leask A; Thompson K
    Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN family of proteins: critical modulators of the tumor cell microenvironment.
    Yeger H; Perbal B
    J Cell Commun Signal; 2016 Sep; 10(3):229-240. PubMed ID: 27517291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
    Leask A
    J Cell Commun Signal; 2009 Jun; 3(2):161-2. PubMed ID: 19475498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCN proteins as potential actionable targets in scleroderma.
    Henrot P; Truchetet ME; Fisher G; Taïeb A; Cario M
    Exp Dermatol; 2019 Jan; 28(1):11-18. PubMed ID: 30329180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.
    Kubota S; Takigawa M
    Clin Sci (Lond); 2015 Feb; 128(3):181-96. PubMed ID: 25294165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the CCN protein family in cancer.
    Kim H; Son S; Shin I
    BMB Rep; 2018 Oct; 51(10):486-492. PubMed ID: 30158025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases.
    Gonzalez D; Brandan E
    Mol Neurobiol; 2019 Aug; 56(8):5911-5916. PubMed ID: 30689195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the CCN genes by vitamin D: A possible adjuvant therapy in the treatment of cancer and fibrosis.
    Piszczatowski RT; Lents NH
    Cell Signal; 2016 Oct; 28(10):1604-13. PubMed ID: 27460560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral CCN gene transfers induce in vitro and in vivo endoplasmic reticulum stress and unfolded protein response.
    Borkham-Kamphorst E; Steffen BT; Van de Leur E; Tihaa L; Haas U; Woitok MM; Meurer SK; Weiskirchen R
    Biochim Biophys Acta; 2016 Nov; 1863(11):2604-2612. PubMed ID: 27452908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Kidney Fibrosis.
    Yokoi H; Mukoyama M
    Methods Mol Biol; 2017; 1489():431-443. PubMed ID: 27734395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.
    Wu Q; Jorgensen M; Song J; Zhou J; Liu C; Pi L
    Gastroenterol Res Pract; 2016; 2016():2313850. PubMed ID: 27829832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual roles of CCN proteins in breast cancer progression.
    Kleer CG
    J Cell Commun Signal; 2016 Sep; 10(3):217-222. PubMed ID: 27520547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CCN family: a new class of inflammation modulators?
    Kular L; Pakradouni J; Kitabgi P; Laurent M; Martinerie C
    Biochimie; 2011 Mar; 93(3):377-88. PubMed ID: 21130134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.